What is Theralogix?
Theralogix operates as a premier provider of research-based vitamins and nutritional supplements, distinguishing itself through a steadfast commitment to NSF certification and ingredient transparency. With a legacy spanning over two decades, the company has cultivated deep trust among healthcare practitioners and consumers alike. Their product portfolio, which addresses specialized needs ranging from fertility support to prostate and general wellness, is underpinned by a philosophy of scientific integrity. By bridging the gap between pharmaceutical-grade testing and consumer accessibility, Theralogix maintains a dominant market position in the wellness sector, effectively catering to a demographic that demands verifiable efficacy in their health regimens.
How much funding has Theralogix raised?
Theralogix has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Theralogix
PPP
Public-Private Partnership
What's next for Theralogix?
With this late-stage financing, Theralogix is well-positioned to accelerate its market penetration and scale its research initiatives. The strategic deployment of this capital will likely focus on expanding its distribution channels and enhancing its digital health infrastructure to better serve a global customer base. As the company moves into its next phase of growth, the focus remains on maintaining the high standards of quality that have defined its brand, while exploring new therapeutic areas that align with its core mission of evidence-based nutritional support. This financial milestone provides the necessary runway to solidify its leadership in the nutraceutical industry.
See full Theralogix company page
